BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye M, Gao R, Chen S, Wei M, Wang J, Zhang B, Wu S, Xu Y, Wu P, Chen X, Ma J, Ma D, Dong K. Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression. J Cell Mol Med 2022. [PMID: 35257481 DOI: 10.1111/jcmm.17258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang R, Wu Y, Zou Z. Combining EZH2 inhibitors with other therapies for solid tumors: more choices for better effects. Epigenomics 2023. [PMID: 36601794 DOI: 10.2217/epi-2022-0320] [Reference Citation Analysis]
2 Zhang L, Zhao F, Li W, Song G, Kasim V, Wu S. The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer. Cancers (Basel) 2022;14. [PMID: 36551518 DOI: 10.3390/cancers14246032] [Reference Citation Analysis]
3 Hayakawa S, Ohishi T, Oishi Y, Isemura M, Miyoshi N. Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. Antioxidants (Basel) 2022;11. [PMID: 36552560 DOI: 10.3390/antiox11122352] [Reference Citation Analysis]
4 Ye M, Chen T, Hu C, Bai J, Zhong Y, Yan L, Kan J, Chen J, Lu F, Li X, Tian Y, Tang Q. Downregulation of FABP5 suppresses mTOR -mediated autophagy via an increase in FASN to promote colorectal cancer progression.. [DOI: 10.21203/rs.3.rs-1961306/v1] [Reference Citation Analysis]
5 Li M, Jiang H, Chen S, Ma Y. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma. Bioengineered 2022;13:11320-41. [PMID: 35491849 DOI: 10.1080/21655979.2022.2068921] [Reference Citation Analysis]